Stryker Orthopaedics — Revenue increased by 0.1% to $2.25B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.9%, from $2.17B to $2.25B. Over 2 years (FY 2022 to FY 2024), Orthopaedics — Revenue shows an upward trend with a 9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share, successful product launches, or higher surgical procedure volumes, while a decrease may signal competitive pressure, pricing headwinds, or a slowdown in elective surgery demand.
This metric represents the total gross revenue generated by the sale of orthopedic products, including reconstructive im...
Comparable to segment-level net sales reported by major medical technology peers in the orthopedics and implants space, such as Zimmer Biomet or DePuy Synthes.
syk_segment_orthopaedics_revenues| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.63B | $1.53B | $1.89B | $1.89B | $1.89B | $1.89B | $2.08B | $2.08B | $2.08B | $2.08B | $2.15B | $2.21B | $2.17B | $2.55B | $2.36B | $2.25B | $2.25B |
| QoQ Change | — | -6.1% | +23.5% | +0.0% | +0.0% | +0.0% | +10.3% | +0.0% | +0.0% | +0.0% | +3.0% | +2.8% | -1.7% | +17.7% | -7.8% | -4.4% | +0.1% |
| YoY Change | — | — | — | +16.0% | +23.5% | — | +10.3% | +10.3% | +10.3% | +10.3% | +3.0% | +5.9% | +4.1% | +22.6% | +9.7% | +2.0% | +3.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.